Paper28166181
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.
Chandra J and 10 others. J Immunother, 2017. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection. Papers, record 28166181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28166181
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft Rejection | Major topic |
| Human papillomavirus 16 | Major topic |
| Papillomavirus Infections | Major topic |
| Papillomavirus Vaccines | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| B7-H1 Antigen | |
| Cell Growth Processes | |
| Female | |
| Humans | |
| Immunity, Cellular | |
| Immunity, Humoral | |
| Mice | |
| Mice, Inbred C57BL | |
| Oncogene Proteins, Viral | |
| Papillomavirus E7 Proteins | |
| Repressor Proteins | |
| Skin | |
| Skin Transplantation | |
| Vaccination | |
| Vaccines, DNA |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20028654 | Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production. | J Immunol | 2010 | https://conductscience.org/library/papers/20028654 | PubMed |
| 2 | 26386540 | Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. | Lancet | 2015 | https://conductscience.org/library/papers/26386540 | PubMed |
| 3 | 19180468 | Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells. | Eur J Immunol | 2009 | https://conductscience.org/library/papers/19180468 | PubMed |
| 4 | 22204816 | Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients. | Immunobiology | 2012 | https://conductscience.org/library/papers/22204816 | PubMed |
| 5 | 26616223 | A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3). | Gynecol Oncol | 2016 | https://conductscience.org/library/papers/26616223 | PubMed |
| 6 | 22525006 | Simultaneous immunisation with a Wilms' tumour 1 epitope and its ubiquitin fusions results in enhanced cell mediated immunity and tumour rejection in C57BL/6 mice. | Mol Immunol | 2012 | https://conductscience.org/library/papers/22525006 | PubMed |
| 7 | 23135914 | PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. | Cancer Res | 2013 | https://conductscience.org/library/papers/23135914 | PubMed |
| 8 | 25063870 | IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. | J Immunol | 2014 | https://conductscience.org/library/papers/25063870 | PubMed |
| 9 | 9275369 | Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity. | Chin Med J (Engl) | 1996 | https://conductscience.org/library/papers/9275369 | PubMed |
| 10 | 19684440 | Molecular mechanisms of human papillomavirus-induced carcinogenesis. | Public Health Genomics | 2009 | https://conductscience.org/library/papers/19684440 | PubMed |
| 11 | 27031095 | Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity. | PLoS One | 2016 | https://conductscience.org/library/papers/27031095 | PubMed |
| 12 | 11738751 | Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. | Vaccine | 2001 | https://conductscience.org/library/papers/11738751 | PubMed |
| 13 | 14985791 | Comparison of HPV DNA vaccines employing intracellular targeting strategies. | Gene Ther | 2004 | https://conductscience.org/library/papers/14985791 | PubMed |
| 14 | 19933862 | Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani. | J Immunol | 2009 | https://conductscience.org/library/papers/19933862 | PubMed |
| 15 | 22540309 | Enhanced cellular immune response elicited by a DNA vaccine fused with Ub against Mycobacterium tuberculosis. | Scand J Immunol | 2012 | https://conductscience.org/library/papers/22540309 | PubMed |
| 16 | 8627712 | Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. | J Virol | 1996 | https://conductscience.org/library/papers/8627712 | PubMed |
| 17 | 25340820 | HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/25340820 | PubMed |
| 18 | 27367787 | Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review. | JAMA Oncol | 2016 | https://conductscience.org/library/papers/27367787 | PubMed |
| 19 | 2542578 | A point mutational analysis of human papillomavirus type 16 E7 protein. | J Virol | 1989 | https://conductscience.org/library/papers/2542578 | PubMed |
| 20 | 20003917 | DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene. | Vaccine | 2010 | https://conductscience.org/library/papers/20003917 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42773168 | Microfluidics-mediated spatial control of mRNA lipid nanoparticles primes translation and enhances vaccine potency. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42773168 | PubMed |
| 42646731 | Preclinical Development of ARV-2001, an Intradermally Administered mRNA-Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646731 | PubMed |
| 42519393 | Oncolytic virus-mediated remodeling of tumor microenvironment enhances efficacy of an HPV16 E6/E7 mRNA vaccine in an HPV-positive tumor. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42519393 | PubMed |
| 42347638 | Complete Genomes of Human Papillomavirus Type 16 Viruses Isolated from Cases of Cervical Neoplasia and Squamous Cell Carcinomas Followed in Latvia in 2012-2024. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347638 | PubMed |
| 41084861 | Recombinant lactococcus lactis expressing HPV-16 E6E7 dual antigens for potential cervical cancer treatment enhances dendritic cell vaccines efficacy. | Future Microbiol | 2025 | https://conductscience.org/library/papers/41084861 | PubMed |
| 40713852 | New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/40713852 | PubMed |
| 39619016 | Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survival. | Clin Transl Immunology | 2024 | https://conductscience.org/library/papers/39619016 | PubMed |
| 39339952 | Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond. | Viruses | 2024 | https://conductscience.org/library/papers/39339952 | PubMed |
| 39035738 | A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. | Front Oncol | 2024 | https://conductscience.org/library/papers/39035738 | PubMed |
| 38919494 | Oropharyngeal cancer and human papillomavirus: a visualization based on bibliometric analysis and topic modeling. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38919494 | PubMed |
| 37675835 | Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37675835 | PubMed |
| 37626903 | Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines. | Cells | 2023 | https://conductscience.org/library/papers/37626903 | PubMed |
| 37550734 | NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice. | BMC Res Notes | 2023 | https://conductscience.org/library/papers/37550734 | PubMed |
| 36497272 | Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497272 | PubMed |
| 36455147 | Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36455147 | PubMed |
| 35445137 | Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35445137 | PubMed |
| 35372036 | An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35372036 | PubMed |
| 35215833 | Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials. | Viruses | 2022 | https://conductscience.org/library/papers/35215833 | PubMed |
| 34805788 | A model of impaired Langerhans cell maturation associated with HPV induced epithelial hyperplasia. | iScience | 2021 | https://conductscience.org/library/papers/34805788 | PubMed |
| 34429969 | Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8+ T cells in the tumor microenvironment. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/34429969 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACKR1 | 2532 | PubTator's text mining | https://conductscience.org/library/genes/2532 | NCBI Gene |
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FLT3LG | 2323 | PubTator's text mining | https://conductscience.org/library/genes/2323 | NCBI Gene |
| HAVCR2 | 84868 | PubTator's text mining | https://conductscience.org/library/genes/84868 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| WT1 | 7490 | PubTator's text mining | https://conductscience.org/library/genes/7490 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28166181
GET https://conductscience.org/api/papers/v1/28166181/references?page=2